Effect of NF-κB p65 antisense oligodeoxynucleotide on transdifferentiation of normal human lens epithelial cells

Chao Liu1, Xiao-Li Wu2, Xin-Yi Wu3

  • 1Department of Ophthalmology, Qilu Hospital, Shandong University, Jinan 250012, Shandong Province, China; Department of Ophthalmology, Central Hospital of Qingdao, Qingdao 266042, Shandong Province, China.

Abstract

Insights

Nuclear factor kappa-B p65 antisense oligodeoxynucleotide (NF-κB p65 ASODN) inhibited transforming growth factor-β2 (TGF-β2)-induced transdifferentiation in human lens epithelial cells. This suggests NF-κB p65 ASODN may be a therapeutic target for posterior capsular opacification.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Molecular Biology

Background:

  • Posterior capsular opacification (PCO) is a common complication after cataract surgery.
  • Transforming growth factor-β2 (TGF-β2) is implicated in the transdifferentiation of lens epithelial cells, a key process in PCO development.
  • Nuclear factor kappa-B p65 (NF-κB p65) signaling pathway activation is observed during TGF-β2-induced transdifferentiation.

Purpose of the Study:

  • To investigate the inhibitory effect of NF-κB p65 antisense oligodeoxynucleotide (ASODN) on TGF-β2-induced transdifferentiation of human lens epithelial cells (HLE B-3) in vitro.
  • To evaluate NF-κB p65 ASODN as a potential therapeutic target for PCO.

Main Methods:

  • Human lens epithelial cells (HLE B-3) were treated with TGF-β2 to induce transdifferentiation.
  • Cells were transfected with NF-κB p65 ASODN or a missense control oligodeoxynucleotide (MSODN).
  • Expression levels of NF-κB p65 mRNA and α-smooth muscle actin (α-SMA) protein were quantified using RT-PCR and ELISA, respectively.

Main Results:

  • TGF-β2 significantly increased the expression of NF-κB p65 mRNA and α-SMA protein in a time-dependent manner.
  • NF-κB p65 ASODN treatment significantly reduced the expression of both NF-κB p65 mRNA and α-SMA protein induced by TGF-β2.
  • NF-κB p65 MSODN and the transfer agent HiPerFect did not show significant inhibitory effects.

Conclusions:

  • NF-κB p65 ASODN effectively antagonizes TGF-β2-induced transdifferentiation of human lens epithelial cells in vitro.
  • The findings support NF-κB p65 ASODN as a promising therapeutic target for preventing or treating posterior capsular opacification.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.5K